Biotechnology division of Century Pharmaceuticals Ltd is established in 2007 to develop novel therapeutic products. The parent company has been manufacturing and marketing chemical active pharmaceutical ingredients for the last 28 years. The first set of molecules undertaken by the biotechnology division are fusion proteins for the treatment of hypersensitivity diseases asthma and Allergies. These products cause targeted apoptosis of mast cells which are the main mediators of asthma and allergic diseases. The products are patented by Yissum Research Company and licensed to Century Pharmaceuticals Ltd. We also are exploring collaborations with other companies and academic research laboratories to develop and commercialize novel molecules. Apart from the development of novel drug molecules we also provide contract research services and non-GMP manufacturing services.
